Cargando…
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
BACKGROUND: The microRNA-205 (miR-205) has been shown to be deregulated in prostate cancer (PCa). Here we continue to investigate the prognostic and therapeutic potential of this microRNA. METHODS: The expression of miR-205 is measured by qRT–PCR and in situ hybridisation in a well-documented PCa co...
Autores principales: | Hagman, Z, Haflidadóttir, B S, Ceder, J A, Larne, O, Bjartell, A, Lilja, H, Edsjö, A, Ceder, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668465/ https://www.ncbi.nlm.nih.gov/pubmed/23571738 http://dx.doi.org/10.1038/bjc.2013.131 |
Ejemplares similares
-
The tumour suppressor miR-34c targets MET in prostate cancer cells
por: Hagman, Z, et al.
Publicado: (2013) -
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2013) -
Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012) -
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
por: Larzabal, L, et al.
Publicado: (2014) -
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
por: Massoner, P, et al.
Publicado: (2014)